Latest News

Topiramate reduces heavy drinking among patients seeking to cut down on alcohol consumption

Heavy alcohol consumption is common in the United States and takes a personal and societal toll, with an annual estimated cost of 3.5 billion. Researchers have shown that the anticonvulsant medication, topiramate, previously shown to reduce drinking in patients committed to abstinence from alcohol, can also be helpful in treating problem drinkers whose aim is to curb their alcohol consumption ? particularly among a specific group of patients whose genetic makeup appears to be linked to the efficacy of the therapy.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • High-dose opioid prescribing continues to climb in Canada

  • Sleep disorders widely undiagnosed in individuals with multiple sclerosis

  • Unemployment for doctoral scientists, engineers below American national average in 2013

  • Mindfulness protects adults' health from the impacts of childhood adversity

  • Epilepsy breakthrough may lead to non-pharmacological therapies

  • To curb violent tendencies, start young

  • Young women involve parent in abortion when anticipating support

  • Everyday discrimination impacts mental health

  • This is your brain on snacks: Brain stimulation affects craving, consumption

  • Largest ever study of awareness during general anesthesia identifies risk factors and consequences

  •